JAC Advance Access published online on November 18, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf221
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Brief
1 Department of Medical Microbiology, University Hospital
Malmö, Lund University, S-205 02 Malmö, Sweden
* Corresponding author. E-mail: kristian.riesbeck{at}mikrobiol.mas.lu.se.
Received 25 March 2002
; revised 16 August 2002
; accepted 27 August 2002
Non-typeable Haemophilus influenzae,
which is a cause of disease in the upper and lower respiratory tract,
can survive intracellularly in human epithelial cells and macrophages.
We studied the in vitro activity of five antibiotics
against intracellular non-typeable H. influenzae in human
type II alveolar epithelial cells. The eukaryotic cells were loaded
with bacteria, and extracellular bacteria were killed by gentamicin.
After the cells were washed, antibiotics were added at concentrations
of 0.12-64 mg/L for 18 h before the numbers of viable intracellular
bacteria were determined. Of the antibiotics tested, ciprofloxacin
and quinupristin/dalfopristin were the most potent agents, followed
by clarithromycin and telithromycin. Ampicillin was not active against
intracellularly localized, non-typeable H. influenzae.
Comparison of the antibacterial activities of ampicillin,
ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin
against intracellular non-typeable Haemophilus influenzae
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. N. A. Qazi, S. E. Harrison, T. Self, P. Williams, and P. J. Hill Real-Time Monitoring of Intracellular Staphylococcus aureus Replication J. Bacteriol., February 15, 2004; 186(4): 1065 - 1077. [Abstract] [Full Text] [PDF] |
||||
